[1]谢晓暄,黄铂渊,宗文静.微小RNA在动脉粥样硬化中的作用及中药干预研究进展?[J].西部中医药,2021,34(11):145-148.[doi:10.12174/j.issn.2096-9600.2021.11.33]
 XIE Xiaoxuan,HUANG Boyuan,ZONG Wenjing.Research Progress of Traditional Chinese Medicine Intervention and the Role of MicroRNA in Atherosclerosis[J].Western Journal of Traditional Chinese Medicine,2021,34(11):145-148.[doi:10.12174/j.issn.2096-9600.2021.11.33]
点击复制

微小RNA在动脉粥样硬化中的作用及中药干预研究进展?
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年11期
页码:
145-148
栏目:
研究进展
出版日期:
2021-11-15

文章信息/Info

Title:
Research Progress of Traditional Chinese Medicine Intervention and the Role of MicroRNA in Atherosclerosis
作者:
谢晓暄 黄铂渊 宗文静
首都医科大学中医药学院,北京 102200
Author(s):
XIE Xiaoxuan HUANG Boyuan ZONG Wenjing
College of Traditional Chinese Medicine, Capital Medical University, Beijing 102200, China
关键词:
动脉粥样硬化微小RNA中药干预
Keywords:
atherosclerosismiRNAherbal intervention
分类号:
R541
DOI:
10.12174/j.issn.2096-9600.2021.11.33
文献标志码:
A
摘要:
对微小RNA(microRNA,miRNA)在动脉粥样硬化(atherosclerosis,AS)中的作用及中药对其的干预进行综述,指出微小RNA能够从细胞自噬、脂质代谢、血管新生和炎症反应等多个方面参与调控动脉粥样硬化的发生发展,中医药能够通过干预微小RNA防治AS。
Abstract:
Through reviewing the role of miRNA in AS and the intervention of herbs on miRNA, it is pointed out that miRNA could participate in the regulation of the occurrence and the development of AS from many aspects, such as autophagy, lipid metabolism, angiogenesis and inflammatory response. Traditional Chinese medicine could prevent and treat AS through intervening microRNA.

相似文献/References:

[1]朱晓娜,李天浩.调脂柔脉颗粒治疗动脉粥样硬化性脑梗死的疗效评价[J].西部中医药,2012,25(10):77.
 ZHU Xiao-na,LI Tian-hao.Evaluation on Clinical Efficacy of TiaoZhi RouMai Granules in Treating Atherosclerotic Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2012,25(11):77.
[2]东红.中风膏对动脉粥样硬化模型家兔血脂水平、血管内皮功能的影响*[J].西部中医药,2013,26(03):25.
 DONG Hong.Effects of ZhongFengGao on Level of Blood Fat and Vascular Endothelial Function of Rabbits with Atherosclerosis[J].Western Journal of Traditional Chinese Medicine,2013,26(11):25.
[3]张和平,谈建新,王敬敏,等.心脑通配方对大鼠颈总动脉粥样硬化斑块中MMP-2的影响[J].西部中医药,2014,27(03):32.
 ZHANG Heping,TAN Jianxin,WANG Jingmin,et al.Effects of XinNaoTong Prescription on MMP-2 in Carotid Atherosclerotic Plaque of Rats[J].Western Journal of Traditional Chinese Medicine,2014,27(11):32.
[4]王建平,梅妍△,李兰青,等.消脂胶囊对家兔代谢综合征动脉粥样硬化的影响[J].西部中医药,2016,29(03):14.
 WANG Jianping,MEI Yan,LI Lanqing,et al.Influence of XiaoZhi Capsules on Metabolic Syndrome Atherosclerosis of the Rabbits[J].Western Journal of Traditional Chinese Medicine,2016,29(11):14.
[5]张淑英,帅丽,张红芳,等.中药干预尿毒症血透患者CRP增高的临床疗效[J].西部中医药,2017,30(10):79.
 ZHANG Shuying,SHUAI Li,ZHANG Hongfang,et al.Clinical Effects of Herbs in Intervening CRP Rise of Uremia Patients with Hemodialysis[J].Western Journal of Traditional Chinese Medicine,2017,30(11):79.
[6]罗永苗,陈朝俊,李玥珺.基于NF-κB探讨参七脉心通胶囊抗动脉粥样硬化的作用机制[J].西部中医药,2018,31(05):8.
 LUO Yongmiao,CHEN Chaojun,LI Yuejun.Study on the Mechanism of ShenQi MaiXinTong Capsules Fighting against Atherosclerosis Based on NF-κB[J].Western Journal of Traditional Chinese Medicine,2018,31(11):8.
[7]于妍,杨阿妮.芪乌调脂颗粒稳定大鼠动脉粥样硬化斑块的作用机制[J].西部中医药,2018,31(07):17.
 YU Yan,YANG Ani.The Mechanism of QiWu TiaoZhi Granules Stabilizing Atheroslcerotic Plaque of the Rats[J].Western Journal of Traditional Chinese Medicine,2018,31(11):17.
[8]刘云,董剑廷△.中西医结合治疗急性心肌梗死心绞痛临床观察[J].西部中医药,2019,32(01):83.
 LIU Yun,DONG Jianting.Clinical Observation on Integrative Medicine in Treating Acute Myocardial Infarction Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2019,32(11):83.
[9]聂忠富,孙小燕,张太平,等.吴茱萸碱抑制动脉粥样硬化大鼠氧化应激和炎症反应的实验研究[J].西部中医药,2019,32(08):12.
 NIE Zhongfu,SUN Xiaoyan,ZHANG Taiping,et al.Experimental Study on Rutecarpine in Inhibiting Oxidative Stress and Inflammatory Reaction of AS Rats[J].Western Journal of Traditional Chinese Medicine,2019,32(11):12.
[10]王准.通脉舒络汤治疗老年冠心病的临床观察[J].西部中医药,2020,33(06):81.[doi:10.12174/j.issn.1004-6852.2020.06.21]
 WANG Zhun.Observation on Clinical Effects of Tongmai Shuluo Tang in Treating Coronary Atherosclerotic Heart Disease in the Elderly[J].Western Journal of Traditional Chinese Medicine,2020,33(11):81.[doi:10.12174/j.issn.1004-6852.2020.06.21]

备注/Memo

备注/Memo:
谢晓暄(1998—),女。研究方向:心血管疾病的中医药防治。国家自然科学基金青年基金(81804016);首都医科大学学生科研创新项目(XSKY2020107)。
更新日期/Last Update: 2022-08-09